{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T08:16:21Z","timestamp":1777968981011,"version":"3.51.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-11888-7","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:26:43Z","timestamp":1777966003000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-modal therapeutic approaches to inflammatory bowel disease: plant-derived compounds, nanoparticle drug delivery systems, and gene-based interventions"],"prefix":"10.1007","volume":"53","author":[{"given":"Arooj","family":"Komal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doua","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Usman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Khalil ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyaba","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hina","family":"Ayub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nokhba","family":"Naqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umair","family":"Ilyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"11888_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40258-016-0272-z","volume":"15","author":"M Kosti\u0107","year":"2017","unstructured":"Kosti\u0107 M, Djakovic L, \u0160uji\u0107 R, Godman B, Jankovi\u0107 SM (2017) Inflammatory Bowel Diseases (Crohn\u00b4s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications. Appl Health Econ Health Policy 15:85\u201393. https:\/\/doi.org\/10.1007\/s40258-016-0272-z","journal-title":"Appl Health Econ Health Policy"},{"key":"11888_CR2","doi-asserted-by":"publisher","unstructured":"Zhou J, Li M, Chen Q, Li X, Chen L, Dong Z, Zhu W, Yang Y, Liu Z, Chen Q (2022) Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun 13. https:\/\/doi.org\/10.1038\/s41467-022-31171-0","DOI":"10.1038\/s41467-022-31171-0"},{"key":"11888_CR3","doi-asserted-by":"publisher","unstructured":"Borowitz SM (2023) The epidemiology of inflammatory bowel disease: Clues to pathogenesis? Front Pediatr 10. https:\/\/doi.org\/10.3389\/fped.2022.1103713","DOI":"10.3389\/fped.2022.1103713"},{"key":"11888_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","volume":"8","author":"J Burisch","year":"2023","unstructured":"Burisch J, Zhao M, Odes S, De Cruz P, Vermeire S, Bernstein CN, Kaplan GG, Duricova D, Greenberg D, Melberg HO, Watanabe M, Ahn HS, Targownik L, Pittet VEH, Annese V, Park KT, Katsanos KH, H\u00f8ivik ML, Krznaric Z, Chaparro M, Loftus EV, Lakatos PL, Gisbert JP, Bemelman W, Moum B, Gearry RB, Kappelman MD, Hart A, Pierik MJ, Andrews JM, Ng SC, D\u2019Inca R, Munkholm P (2023) The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission, Lancet Gastroenterol. Hepatol 8:458\u2013492. https:\/\/doi.org\/10.1016\/S2468-1253(23)00003-1","journal-title":"Hepatol"},{"key":"11888_CR5","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s11894-019-0705-6","volume":"21","author":"JW Windsor","year":"2019","unstructured":"Windsor JW, Kaplan GG (2019) Evolving Epidemiology of IBD. Curr Gastroenterol Rep 21:40. https:\/\/doi.org\/10.1007\/s11894-019-0705-6","journal-title":"Curr Gastroenterol Rep"},{"key":"11888_CR6","doi-asserted-by":"publisher","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","volume":"287","author":"SH Itzkowitz","year":"2004","unstructured":"Itzkowitz SH, Yio X (2004) Inflammation and cancer - IV. Colorectal cancer in inflammatory bowel disease: The role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7\u201317. https:\/\/doi.org\/10.1152\/ajpgi.00079.2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"11888_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.2174\/13816128113199990417","volume":"20","author":"K Gyires","year":"2014","unstructured":"Gyires K, Toth E, Zadori S (2014) Gut Inflammation: Current Update on Pathophysiology, Molecular Mechanism and Pharmacological Treatment Modalities. Curr Pharm Des 20:1063\u20131081. https:\/\/doi.org\/10.2174\/13816128113199990417","journal-title":"Curr Pharm Des"},{"key":"11888_CR8","doi-asserted-by":"publisher","first-page":"7026","DOI":"10.3390\/jcm13237026","volume":"13","author":"T Purnak","year":"2024","unstructured":"Purnak T, Ertan A (2024) Optimal Management of Patients with Moderate-to-Severe Inflammatory Bowel Disease. J Clin Med 13:7026. https:\/\/doi.org\/10.3390\/jcm13237026","journal-title":"J Clin Med"},{"key":"11888_CR9","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/MIB.0000000000000620","volume":"22","author":"A Mikocka-Walus","year":"2016","unstructured":"Mikocka-Walus A, Knowles SR, Keefer L, Graff L (2016) Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases, Inflamm. Bowel Dis 22:752\u2013762. https:\/\/doi.org\/10.1097\/MIB.0000000000000620","journal-title":"Bowel Dis"},{"key":"11888_CR10","doi-asserted-by":"publisher","unstructured":"MingZhen ZZ, Viennois E, Prasad MM (2016) Edible ginger-derived nanoparticles: a novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. 321\u2013340. https:\/\/doi.org\/10.5555\/20163240943","DOI":"10.5555\/20163240943"},{"key":"11888_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4103\/0975-8453.59516","volume":"1","author":"S Das","year":"2010","unstructured":"Das S, Deshmukh R, Jha AK (2010) Role of Natural Polymers in the Development of Multiparticulate Systems for Colon Drug Targeting. Syst Reviews Pharm 1:79. https:\/\/doi.org\/10.4103\/0975-8453.59516","journal-title":"Syst Reviews Pharm"},{"key":"11888_CR12","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.addr.2013.10.001","volume":"71","author":"C Lautenschl\u00e4ger","year":"2014","unstructured":"Lautenschl\u00e4ger C, Schmidt C, Fischer D, Stallmach A (2014) Drug delivery strategies in the therapy of inflammatory bowel disease. Adv Drug Deliv Rev 71:58\u201376. https:\/\/doi.org\/10.1016\/j.addr.2013.10.001","journal-title":"Adv Drug Deliv Rev"},{"key":"11888_CR13","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.2217\/nnm-2019-0191","volume":"14","author":"R Nunes","year":"2019","unstructured":"Nunes R, Das Neves J, Sarmento B (2019) Nanoparticles for the regulation of intestinal inflammation: Opportunities and challenges. Nanomedicine 14:2631\u20132644. https:\/\/doi.org\/10.2217\/nnm-2019-0191","journal-title":"Nanomedicine"},{"key":"11888_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrg3978","volume":"16","author":"A Wittrup","year":"2015","unstructured":"Wittrup A, Lieberman J (2015) Knocking down disease: A progress report on siRNA therapeutics. Nat Rev Genet 16:543\u2013552. https:\/\/doi.org\/10.1038\/nrg3978","journal-title":"Nat Rev Genet"},{"key":"11888_CR15","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.2147\/IJN.S116902","volume":"11","author":"J Guo","year":"2016","unstructured":"Guo J, Jiang X, Gui S (2016) RNA interference-based nanosystems for inflammatory bowel disease therapy. Int J Nanomed 11:5287\u20135310. https:\/\/doi.org\/10.2147\/IJN.S116902","journal-title":"Int J Nanomed"},{"key":"11888_CR16","doi-asserted-by":"publisher","first-page":"105073","DOI":"10.1016\/j.jff.2022.105073","volume":"93","author":"PS Loubet Filho","year":"2022","unstructured":"Loubet Filho PS, Dias TO, de Reis VH, Moya AMTM, dos Santos EF, Cazarin CBB (2022) Feed your gut: Functional food to improve the pathophysiology of inflammatory bowel disease. J Funct Foods 93:105073. https:\/\/doi.org\/10.1016\/j.jff.2022.105073","journal-title":"J Funct Foods"},{"key":"11888_CR17","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/ijms24021526","volume":"24","author":"A Saez","year":"2023","unstructured":"Saez A, Herrero-Fernandez B, Gomez-Bris R, S\u00e1nchez-Martinez H, Gonzalez-Granado JM (2023) Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. Int J Mol Sci 24:1526. https:\/\/doi.org\/10.3390\/ijms24021526","journal-title":"Int J Mol Sci"},{"key":"11888_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.advms.2016.09.001","volume":"62","author":"Z Kmie\u0107","year":"2017","unstructured":"Kmie\u0107 Z, Cyman M, \u015alebioda TJ (2017) Cells of the innate and adaptive immunity and their interactions in inflammatory bowel disease. Adv Med Sci 62:1\u201316. https:\/\/doi.org\/10.1016\/j.advms.2016.09.001","journal-title":"Adv Med Sci"},{"key":"11888_CR19","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1111\/febs.15236","volume":"287","author":"IM Sayed","year":"2020","unstructured":"Sayed IM, Suarez K, Lim E, Singh S, Pereira M, Ibeawuchi SR, Katkar G, Dunkel Y, Mittal Y, Chattopadhyay R, Guma M, Boland BS, Dulai PS, Sandborn WJ, Ghosh P, Das S (2020) Host engulfment pathway controls inflammation in inflammatory bowel disease. FEBS J 287:3967\u20133988. https:\/\/doi.org\/10.1111\/febs.15236","journal-title":"FEBS J"},{"key":"11888_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00018-011-0837-9","volume":"69","author":"E Glocker","year":"2012","unstructured":"Glocker E, Grimbacher B (2012) Inflammatory bowel disease: Is it a primary immunodeficiency? Cell Mol Life Sci 69:41\u201348. https:\/\/doi.org\/10.1007\/s00018-011-0837-9","journal-title":"Cell Mol Life Sci"},{"key":"11888_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.biomaterials.2016.06.018","volume":"101","author":"M Zhang","year":"2016","unstructured":"Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, Han MK, Xiao B, Xu C, Srinivasan S, Merlin D (2016) Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials 101:321\u2013340. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.06.018","journal-title":"Biomaterials"},{"key":"11888_CR22","doi-asserted-by":"publisher","first-page":"114323","DOI":"10.5812\/jjnpp.114323","volume":"17","author":"N Yazdani","year":"2022","unstructured":"Yazdani N, Hossini SE, Edalatmanesh MA (2022) Anti-inflammatory Effect of Aloe vera Extract on Inflammatory Cytokines of Rats Fed with a High-Fat Diet (HFD), Jundishapur J. Nat Pharm Prod 17:114323. https:\/\/doi.org\/10.5812\/jjnpp.114323","journal-title":"Nat Pharm Prod"},{"key":"11888_CR23","doi-asserted-by":"publisher","unstructured":"Naini MA, Zargari-Samadnejad A, Mehrvarz S, Tanideh R, Ghorbani M, Dehghanian A, Hasanzarrini M, Banaee F, Koohi-Hosseinabadi O, Tanideh N, Iraji A (2021) Anti-Inflammatory, Antioxidant, and Healing-Promoting Effects of Aloe vera Extract in the Experimental Colitis in Rats, Evidence-Based Complementary and Alternative Medicine 9945244. https:\/\/doi.org\/10.1155\/2021\/9945244","DOI":"10.1155\/2021\/9945244"},{"key":"11888_CR24","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.3390\/nu13041343","volume":"13","author":"B Venkataraman","year":"2021","unstructured":"Venkataraman B, Almarzooqi S, Raj V, Alhassani AT, Alhassani AS, Ahmed KJ, Subramanian VS, Ojha SK, Attoub S, Adrian TE, Subramanya SB (2021) Thymoquinone, a dietary bioactive compound, exerts anti-inflammatory effects in colitis by stimulating expression of the colonic epithelial ppar-\u03b3 transcription factor. Nutrients 13:1343. https:\/\/doi.org\/10.3390\/nu13041343","journal-title":"Nutrients"},{"key":"11888_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5152\/tjg.2019.18342","volume":"30","author":"W Yue","year":"2019","unstructured":"Yue W, Liu Y, Li X, Lv L, Huang J, Liu J (2019) Curcumin ameliorates dextran sulfate sodium-induced colitis in mice via regulation of autophagy and intestinal immunity. Turkish J Gastroenterol 30:290\u2013298. https:\/\/doi.org\/10.5152\/tjg.2019.18342","journal-title":"Turkish J Gastroenterol"},{"key":"11888_CR26","doi-asserted-by":"publisher","first-page":"651813","DOI":"10.3389\/fphar.2021.651813","volume":"12","author":"C Li","year":"2021","unstructured":"Li C, Wu G, Zhao H, Dong N, Wu B, Chen Y, Lu Q (2021) Natural-Derived Polysaccharides From Plants, Mushrooms, and Seaweeds for the Treatment of Inflammatory Bowel Disease. Front Pharmacol 12:651813. https:\/\/doi.org\/10.3389\/fphar.2021.651813","journal-title":"Front Pharmacol"},{"key":"11888_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/app10238465","volume":"10","author":"J Rocha","year":"2020","unstructured":"Rocha J, Leandro R, Direito R, Gon\u00e7alves M, Duarte MP, Fernandes A, Sepodes B, Figueira ME (2020) Attenuation of colonic injury and inflammation by administration of a phenolic extract of summer savory (Satureja hortensis l.) in experimental inflammatory bowel disease in mice. Appl Sci (Switzerland) 10:1\u201319. https:\/\/doi.org\/10.3390\/app10238465","journal-title":"Appl Sci (Switzerland)"},{"key":"11888_CR28","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jconrel.2020.10.042","volume":"331","author":"THT Nguyen","year":"2021","unstructured":"Nguyen THT, Trinh NT, Tran HN, Tran HT, Le PQ, Ngo DN, Tran-Van H, Van Vo T, Vong LB, Nagasaki Y (2021) Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease. J Controlled Release 331:515\u2013524. https:\/\/doi.org\/10.1016\/j.jconrel.2020.10.042","journal-title":"J Controlled Release"},{"key":"11888_CR29","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/molecules23051062","volume":"23","author":"Z Wang","year":"2018","unstructured":"Wang Z, Wu X, Wang CL, Wang L, Sun C, Zhang DB, Liu JL, Liang YN, Tang DX, Tang ZS (2018) Tryptanthrin protects mice against dextran sulfate sodium-induced colitis through inhibition of TNF-\u03b1\/NF-\u03baB and IL-6\/STAT3 pathways. Molecules 23:1062. https:\/\/doi.org\/10.3390\/molecules23051062","journal-title":"Molecules"},{"key":"11888_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/molecules29010241","volume":"29","author":"Q Wan","year":"2024","unstructured":"Wan Q, Huang J, Xiao Q, Zhang Z, Zhang Z, Huang L, Deng Y, Deng B, Zhao H, Zhong Y, Liu D (2024) Astragalus Polysaccharide Alleviates Ulcerative Colitis by Regulating the Balance of mTh17\/mTreg Cells through TIGIT\/CD155 Signaling. Molecules 29:241. https:\/\/doi.org\/10.3390\/molecules29010241","journal-title":"Molecules"},{"key":"11888_CR31","doi-asserted-by":"publisher","first-page":"109108","DOI":"10.1016\/j.intimp.2022.109108","volume":"111","author":"Y Zhong","year":"2022","unstructured":"Zhong Y, Xiao Q, Kang Z, Huang J, Ge W, Wan Q, Wang H, Zhou W, Zhao H, Liu D (2022) Astragalus polysaccharide alleviates ulcerative colitis by regulating the balance of Tfh\/Treg cells. Int Immunopharmacol 111:109108. https:\/\/doi.org\/10.1016\/j.intimp.2022.109108","journal-title":"Int Immunopharmacol"},{"key":"11888_CR32","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.ijbiomac.2020.10.259","volume":"166","author":"L Cui","year":"2021","unstructured":"Cui L, Guan X, Ding W, Luo Y, Wang W, Bu W, Song J, Tan X, Sun E, Ning Q, Liu G, Jia X, Feng L (2021) Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota. Int J Biol Macromol 166:1035\u20131045. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.10.259","journal-title":"Int J Biol Macromol"},{"key":"11888_CR33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/nu14030416","volume":"14","author":"A Giacosa","year":"2022","unstructured":"Giacosa A, Riva A, Petrangolini G, Allegrini P, Fazia T, Bernardinelli L, Peroni G, Rondanelli M (2022) Beneficial Effects on Abdominal Bloating with an Innovative Food-Grade Formulation of Curcuma longa and Boswellia serrata Extracts in Subjects with Irritable Bowel Syndrome and Small Bowel Dysbiosis. Nutrients 14:416. https:\/\/doi.org\/10.3390\/nu14030416","journal-title":"Nutrients"},{"key":"11888_CR34","doi-asserted-by":"publisher","first-page":"174730","DOI":"10.1016\/J.EJPHAR.2021.174730","volume":"916","author":"J Zhang","year":"2022","unstructured":"Zhang J, Xu X, Li N, Cao L, Sun Y, Wang J, He S, Si J, Qing D (2022) Licoflavone B, an isoprene flavonoid derived from licorice residue, relieves dextran sodium sulfate-induced ulcerative colitis by rebuilding the gut barrier and regulating intestinal microflora. Eur J Pharmacol 916:174730. https:\/\/doi.org\/10.1016\/J.EJPHAR.2021.174730","journal-title":"Eur J Pharmacol"},{"key":"11888_CR35","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.2217\/NNM-2018-0415","volume":"14","author":"M Zeeshan","year":"2019","unstructured":"Zeeshan M, Ali H, Khan S, Mukhtar M, Khan MI, Arshad M (2019) Glycyrrhizic acid-loaded pH-sensitive Poly-(Lactic-Co-Glycolic Acid) Nanoparticles for the Amelioration of Inflammatory Bowel Disease. Nanomedicine 14:1945\u20131969. https:\/\/doi.org\/10.2217\/NNM-2018-0415","journal-title":"Nanomedicine"},{"key":"11888_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ctim.2019.01.015","volume":"43","author":"SM Barbalho","year":"2019","unstructured":"Barbalho SM, Bosso H, de Salzedas-Pescinini LM (2019) Alvares Goulart, Green tea: A possibility in the therapeutic approach of inflammatory bowel diseases? Green tea and inflammatory bowel diseases. Complement Ther Med 43:148\u2013153. https:\/\/doi.org\/10.1016\/j.ctim.2019.01.015","journal-title":"Complement Ther Med"},{"key":"11888_CR37","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/NRGASTRO.2011.172","volume":"8","author":"KM Taylor","year":"2011","unstructured":"Taylor KM, Irving PM (2011) Optimization of conventional therapy in patients with IBD. Nat Rev Gastroenterol Hepatol 8:646\u2013656. https:\/\/doi.org\/10.1038\/NRGASTRO.2011.172","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11888_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/J.1365-2036.2008.03751.X","volume":"28","author":"GR Lichtenstein","year":"2008","unstructured":"Lichtenstein GR, Kamm MA (2008) Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis\u2013methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa. Aliment Pharmacol Ther 28:663\u2013673. https:\/\/doi.org\/10.1111\/J.1365-2036.2008.03751.X","journal-title":"Aliment Pharmacol Ther"},{"key":"11888_CR39","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","volume":"126","author":"RB Sartor","year":"2004","unstructured":"Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620\u20131633. https:\/\/doi.org\/10.1053\/j.gastro.2004.03.024","journal-title":"Gastroenterology"},{"key":"11888_CR40","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.amjgastroenterol.2003.11.001","volume":"98","author":"F Navarro","year":"2003","unstructured":"Navarro F, Hanauer SB (2003) Treatment of inflammatory bowel disease: safety and tolerability issues. Am J Gastroenterol 98:S18\u2013S23","journal-title":"Am J Gastroenterol"},{"key":"11888_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/IBD.20608","volume":"15","author":"KT Thia","year":"2009","unstructured":"Thia KT, Mahadevan U, Feagan BG, Wong C, Cockeram A, Bitton A, Bersntein CN, Sandborn WJ (2009) Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn\u2019s disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis 15:17\u201324. https:\/\/doi.org\/10.1002\/IBD.20608","journal-title":"Inflamm Bowel Dis"},{"key":"11888_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000296.PUB3\/ABSTRACT","author":"CH Seow","year":"2008","unstructured":"Seow CH, Benchimol EI, Griffiths AM, Otley AR, Steinhart AH (2008) Budesonide for induction of remission in Crohn\u2019s disease. Cochrane Database Syst Reviews. https:\/\/doi.org\/10.1002\/14651858.CD000296.PUB3\/ABSTRACT","journal-title":"Cochrane Database Syst Reviews"},{"key":"11888_CR43","doi-asserted-by":"publisher","unstructured":"Timmer A, Patton PH, Chande N, Mcdonald JW, Macdonald JK (2016) Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Reviews. https:\/\/doi.org\/10.1002\/14651858.CD000478.PUB4\/PDF\/FULL","DOI":"10.1002\/14651858.CD000478.PUB4\/PDF\/FULL"},{"key":"11888_CR44","doi-asserted-by":"publisher","first-page":"250","DOI":"10.5217\/IR.2015.13.3.250","volume":"13","author":"S Yamada","year":"2015","unstructured":"Yamada S, Yoshino T, Matsuura M, Kimura M, Koshikawa Y, Minami N, Toyonaga T, Honzawa Y, Nakase H (2015) Efficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative Colitis. Intest Res 13:250. https:\/\/doi.org\/10.5217\/IR.2015.13.3.250","journal-title":"Intest Res"},{"key":"11888_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00535-016-1283-0","volume":"52","author":"HC hey Chan","year":"2017","unstructured":"hey Chan HC, Ng SC (2017) Emerging biologics in inflammatory bowel disease. J Gastroenterol 52:141\u2013150. https:\/\/doi.org\/10.1007\/s00535-016-1283-0","journal-title":"J Gastroenterol"},{"key":"11888_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.15403\/jgld-4229","volume":"31","author":"G Tarapatzi","year":"2022","unstructured":"Tarapatzi G, Filidou E, Kandilogiannakis L, Vradelis S, Kolios G (2022) Biomarkers in Inflammatory Bowel Diseases: Predicting the Indication and the Effect of Biologics. J Gastrointest Liver Dis 31:229\u2013243. https:\/\/doi.org\/10.15403\/jgld-4229","journal-title":"J Gastrointest Liver Dis"},{"key":"11888_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1136\/flgastro-2023-102400","volume":"15","author":"S Honap","year":"2023","unstructured":"Honap S, Agorogianni A, Colwill MJ, Mehta SK, Donovan F, Pollok R, Poullis A, Patel K (2023) JAK inhibitors for inflammatory bowel disease: recent advances. Frontline Gastroenterol 15:59\u201369. https:\/\/doi.org\/10.1136\/flgastro-2023-102400","journal-title":"Frontline Gastroenterol"},{"key":"11888_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/S11938-025-00484-6","volume":"23","author":"N Loganantharaj","year":"2025","unstructured":"Loganantharaj N, Mishra K, Charabaty A (2025) How To Safely Use JAK Inhibitors in Patients with Inflammatory Bowel Disease. Curr Treat Options Gastroenterol 23:19\u2013. https:\/\/doi.org\/10.1007\/S11938-025-00484-6","journal-title":"Curr Treat Options Gastroenterol"},{"key":"11888_CR49","doi-asserted-by":"publisher","first-page":"111465","DOI":"10.1016\/J.MATDES.2022.111465","volume":"225","author":"S Lin","year":"2023","unstructured":"Lin S, Zhao H, Xu C, Zhang P, Mei X, Jiang D (2023) Sulfasalazine-loaded nanoparticles for efficient inflammatory bowel disease therapy via ROS-scavenging strategy. Mater Des 225:111465. https:\/\/doi.org\/10.1016\/J.MATDES.2022.111465","journal-title":"Mater Des"},{"key":"11888_CR50","doi-asserted-by":"publisher","unstructured":"Xu C, Chen S, Chen C, Ming Y, Du J, Mu J, Luo F, Huang D, Wang N, Lin Z, Weng Z (2022) Colon-targeted oral nanoparticles based on ROS-scavenging hydroxyethyl starch-curcumin conjugates for efficient inflammatory bowel disease therapy. Int J Pharm 623. https:\/\/doi.org\/10.1016\/J.IJPHARM.2022.121884","DOI":"10.1016\/J.IJPHARM.2022.121884"},{"key":"11888_CR51","doi-asserted-by":"publisher","first-page":"102861","DOI":"10.1016\/j.jddst.2021.102861","volume":"67","author":"S Yener","year":"2022","unstructured":"Yener S, Akbulut K, Karaku\u015f R, Erdo\u011fan D, Acart\u00fcrk F (2022) Development of melatonin loaded pectin nanoparticles for the treatment of inflammatory bowel disease: In vitro and in vivo studies. J Drug Deliv Sci Technol 67:102861. https:\/\/doi.org\/10.1016\/j.jddst.2021.102861","journal-title":"J Drug Deliv Sci Technol"},{"key":"11888_CR52","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/J.JCIS.2022.06.088","volume":"626","author":"X Ma","year":"2022","unstructured":"Ma X, Gong H, Liu Y, Liu Y, Ogino K, Xing R, Yan X (2022) Orally administered covalently-assembled antioxidative peptide nanoparticles for inflammatory bowel disease therapy. J Colloid Interface Sci 626:156\u2013166. https:\/\/doi.org\/10.1016\/J.JCIS.2022.06.088","journal-title":"J Colloid Interface Sci"},{"key":"11888_CR53","doi-asserted-by":"publisher","first-page":"112038","DOI":"10.1016\/J.MSEC.2021.112038","volume":"124","author":"JM Soni","year":"2021","unstructured":"Soni JM, Sardoiwala MN, Choudhury SR, Sharma SS, Karmakar S (2021) Melatonin-loaded chitosan nanoparticles endows nitric oxide synthase 2 mediated anti-inflammatory activity in inflammatory bowel disease model. Mater Sci Eng C Mater Biol Appl 124:112038. https:\/\/doi.org\/10.1016\/J.MSEC.2021.112038","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"11888_CR54","doi-asserted-by":"publisher","first-page":"118555","DOI":"10.1016\/J.LFS.2020.118555","volume":"262","author":"M Naserifar","year":"2020","unstructured":"Naserifar M, Hosseinzadeh H, Abnous K, Mohammadi M, Taghdisi SM, Ramezani M, Alibolandi M (2020) Oral delivery of folate-targeted resveratrol-loaded nanoparticles for inflammatory bowel disease therapy in rats. Life Sci 262:118555. https:\/\/doi.org\/10.1016\/J.LFS.2020.118555","journal-title":"Life Sci"},{"key":"11888_CR55","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.carbpol.2017.12.021","volume":"189","author":"Q Sun","year":"2018","unstructured":"Sun Q, Luan L, Arif M, Li J, Dong QJ, Gao Y, Chi Z, Liu CG (2018) Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases. Carbohydr Polym 189:352\u2013359. https:\/\/doi.org\/10.1016\/j.carbpol.2017.12.021","journal-title":"Carbohydr Polym"},{"key":"11888_CR56","doi-asserted-by":"publisher","unstructured":"Yan M, Zhu L, Wu S, Cao Y, Mou N, Chi Q, Wang G, Zhong Y, Wu W (2022) ROS responsive polydopamine nanoparticles to relieve oxidative stress and inflammation for ameliorating acute inflammatory bowel.Biomaterials advances 142. 213126. https:\/\/doi.org\/10.1016\/j.bioadv.2022.213126","DOI":"10.1016\/j.bioadv.2022.213126"},{"key":"11888_CR57","doi-asserted-by":"publisher","first-page":"129137","DOI":"10.1016\/j.cej.2021.129137","volume":"416","author":"J Wang","year":"2021","unstructured":"Wang J, Tao Z, Tian T, Qiu J, Qian H, Zha Z, Miao Z, Ma Y, Wang H (2021) Polyoxometalate nanoclusters: A potential preventative and therapeutic drug for inflammatory bowel disease. Chem Eng J 416:129137. https:\/\/doi.org\/10.1016\/j.cej.2021.129137","journal-title":"Chem Eng J"},{"key":"11888_CR58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.fmre.2022.07.002","volume":"5","author":"F Wang","year":"2025","unstructured":"Wang F, Li Q, Xu T, Li Z, Jiang Y, Ma Y, Li X, Wang W, Qian H (2025) An orally administered gold nanocluster with ROS scavenging for inflammatory bowel disease treatment. Fundamental Res 5:381\u2013390. https:\/\/doi.org\/10.1016\/j.fmre.2022.07.002","journal-title":"Fundamental Res"},{"key":"11888_CR59","doi-asserted-by":"publisher","unstructured":"Huang C, Xu J, Li J, He S, Xu H, Ren X, Singh V, Wu L, Zhang J (2022) Hydrogen peroxide responsive covalent cyclodextrin framework for targeted therapy of inflammatory bowel disease. Carbohydr Polym 285. https:\/\/doi.org\/10.1016\/j.carbpol.2022.119252","DOI":"10.1016\/j.carbpol.2022.119252"},{"key":"11888_CR60","doi-asserted-by":"publisher","unstructured":"Zhang C, Wang H, Yang X, Fu Z, Ji X, Shi Y, Zhong J, Hu W, Ye Y, Wang Z, Ni D (2022) Oral zero-valent-molybdenum nanodots for inflammatory bowel disease therapy. Sci Adv 8. https:\/\/doi.org\/10.1126\/SCIADV.ABP9882","DOI":"10.1126\/SCIADV.ABP9882"},{"key":"11888_CR61","doi-asserted-by":"publisher","first-page":"15026","DOI":"10.1021\/ACSNANO.2C06151","volume":"16","author":"R Li","year":"2022","unstructured":"Li R, Fan Y, Liu L, Ma H, Gong D, Miao Z, Wang H, Zha Z (2022) Ultrathin Hafnium Disulfide Atomic Crystals with ROS-Scavenging and Colon-Targeting Capabilities for Inflammatory Bowel Disease Treatment. ACS Nano 16:15026\u201315041. https:\/\/doi.org\/10.1021\/ACSNANO.2C06151","journal-title":"ACS Nano"},{"key":"11888_CR62","doi-asserted-by":"publisher","first-page":"1025155","DOI":"10.3389\/FBIOE.2022.1025155","volume":"10","author":"C Wang","year":"2022","unstructured":"Wang C, Guo Z, Liang J, Li N, Song R, Luo L, Ai Y, Li X, Tang S (2022) An oral delivery vehicle based on konjac glucomannan acetate targeting the colon for inflammatory bowel disease therapy. Front Bioeng Biotechnol 10:1025155. https:\/\/doi.org\/10.3389\/FBIOE.2022.1025155","journal-title":"Front Bioeng Biotechnol"},{"key":"11888_CR63","doi-asserted-by":"publisher","first-page":"55966","DOI":"10.1021\/ACSAMI.1C19457","volume":"13","author":"Z Le","year":"2021","unstructured":"Le Z, He Z, Liu H, Liu L, Liu Z, Chen Y (2021) Antioxidant Enzymes Sequestered within Lipid-Polymer Hybrid Nanoparticles for the Local Treatment of Inflammatory Bowel Disease. ACS Appl Mater Interfaces 13:55966\u201355977. https:\/\/doi.org\/10.1021\/ACSAMI.1C19457","journal-title":"ACS Appl Mater Interfaces"},{"key":"11888_CR64","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/S11427-021-2001-0","volume":"65","author":"X Liao","year":"2022","unstructured":"Liao X, Zhao Z, Li H, Wu B, Huo J, Li L, Li X, Cao X, Xia M, Wang C, Bai C (2022) Fullerene nanoparticles for the treatment of ulcerative colitis, Sci. China Life Sci 65:1146\u20131156. https:\/\/doi.org\/10.1007\/S11427-021-2001-0","journal-title":"China Life Sci"},{"key":"11888_CR65","doi-asserted-by":"publisher","first-page":"118982","DOI":"10.1016\/J.IJPHARM.2019.118982","volume":"576","author":"SM El-Hady","year":"2020","unstructured":"El-Hady SM, AbouGhaly MHH, El-Ashmoony MM, Helmy HS, El-Gazayerly ON (2020) Colon targeting of celecoxib nanomixed micelles using pulsatile drug delivery systems for the prevention of inflammatory bowel disease. Int J Pharm 576:118982. https:\/\/doi.org\/10.1016\/J.IJPHARM.2019.118982","journal-title":"Int J Pharm"},{"key":"11888_CR66","doi-asserted-by":"publisher","first-page":"111582","DOI":"10.1016\/J.MSEC.2020.111582","volume":"119","author":"A Ahmad","year":"2021","unstructured":"Ahmad A, Ansari MM, Mishra RK, Kumar A, Vyawahare A, Verma RK, Raza SS, Khan R (2021) Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis. Mater Sci Eng C Mater Biol Appl 119:111582. https:\/\/doi.org\/10.1016\/J.MSEC.2020.111582","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"11888_CR67","doi-asserted-by":"publisher","first-page":"121531","DOI":"10.1016\/j.ijpharm.2022.121531","volume":"616","author":"Z Vaezi","year":"2022","unstructured":"Vaezi Z, Asadzadeh Aghdaei H, Sedghi M, Mahdavian R, Molakarimi M, Hashemi N, Naderi-Manesh H (2022) Hemoglobin bio-adhesive nanoparticles as a colon-specific delivery system for sustained release of 5-aminosalicylic acid in the effective treatment of inflammatory bowel disease. Int J Pharm 616:121531. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.121531","journal-title":"Int J Pharm"},{"key":"11888_CR68","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.2147\/IJN.S291090","volume":"16","author":"C Gao","year":"2021","unstructured":"Gao C, Yu S, Zhang X, Dang Y, Han DD, Liu X, Han J, Hui M (2021) Dual Functional Eudragit\u00ae S100\/L30D-55 and PLGA Colon-Targeted Nanoparticles of Iridoid Glycoside for Improved Treatment of Induced Ulcerative Colitis. Int J Nanomed 16:1405\u20131422. https:\/\/doi.org\/10.2147\/IJN.S291090","journal-title":"Int J Nanomed"},{"key":"11888_CR69","doi-asserted-by":"publisher","first-page":"213002","DOI":"10.1016\/j.bioadv.2022.213002","volume":"139","author":"X Bai","year":"2022","unstructured":"Bai X, Feng Z, Peng S, Zhu T, Jiao L, Mao N, Gu P, Liu Z, Yang Y, Wang D (2022) Chitosan-modified Phellinus igniarius polysaccharide PLGA nanoparticles ameliorated inflammatory bowel disease. Biomaterials Adv 139:213002. https:\/\/doi.org\/10.1016\/j.bioadv.2022.213002","journal-title":"Biomaterials Adv"},{"key":"11888_CR70","doi-asserted-by":"publisher","unstructured":"Xu H, Luo R, Dong L, Pu X, Chen Q, Ye N, Qi S, Han X, Nie W, Fu C, Hu Y, Zhang J, Gao F (2022) pH\/ROS dual-sensitive and chondroitin sulfate wrapped poly (\u03b2-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis. Nanomedicine 39. https:\/\/doi.org\/10.1016\/j.nano.2021.102461","DOI":"10.1016\/j.nano.2021.102461"},{"key":"11888_CR71","doi-asserted-by":"publisher","first-page":"6193","DOI":"10.1021\/acs.molpharmaceut.4c00499","volume":"21","author":"H Wu","year":"2024","unstructured":"Wu H, Shi C, Li Q, Wang L, Wang R, Chen F, Li R, Guo X, Chen Y, She J (2024) Oral Administration of Bioactive Nanoparticulates for Inflammatory Bowel Disease Therapy by Mitigating Oxidative Stress and Restoring Intestinal Microbiota Homeostasis. Mol Pharm 21:6193\u20136205. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00499","journal-title":"Mol Pharm"},{"key":"11888_CR72","doi-asserted-by":"publisher","first-page":"2405159","DOI":"10.1002\/adhm.202405159","volume":"14","author":"N Zhang","year":"2025","unstructured":"Zhang N, Zhang X, Li J, Li B, Wang S, Liu X, Meng H, Zhu M (2025) Development of Akkermansia Muciniphila Membrane-Coated Mesoporous Silica Nanoparticles with a Cerium Oxide Core for Inflammatory Bowel Disease Treatment. Adv Healthc Mater 14:2405159. https:\/\/doi.org\/10.1002\/adhm.202405159","journal-title":"Adv Healthc Mater"},{"key":"11888_CR73","doi-asserted-by":"publisher","first-page":"33081","DOI":"10.1021\/acsami.4c05214","volume":"16","author":"Q Li","year":"2024","unstructured":"Li Q, Liu W, Liu K, Dong Z, Kong W, Lu X, Wei Y, Wu W, Yang J, Qi J (2024) The Role of Nanoparticle Morphology on Enhancing Delivery of Budesonide for Treatment of Inflammatory Bowel Disease. ACS Appl Mater Interfaces 16:33081\u201333092. https:\/\/doi.org\/10.1021\/acsami.4c05214","journal-title":"ACS Appl Mater Interfaces"},{"key":"11888_CR74","doi-asserted-by":"publisher","first-page":"2544689","DOI":"10.1080\/10717544.2025.2544689","volume":"32","author":"Z Lin","year":"2025","unstructured":"Lin Z, Zhao Z, Lin X, Yang Z, Wang L, Xi R, Long D (2025) Advances in oral treatment of inflammatory bowel disease using protein-based nanoparticle drug delivery systems. Drug Deliv 32:2544689. https:\/\/doi.org\/10.1080\/10717544.2025.2544689","journal-title":"Drug Deliv"},{"key":"11888_CR75","doi-asserted-by":"publisher","first-page":"120935","DOI":"10.1016\/j.ijpharm.2021.120935","volume":"606","author":"P Diez-Echave","year":"2021","unstructured":"Diez-Echave P, Ruiz-Malag\u00f3n AJ, Molina-Tijeras JA, Hidalgo-Garc\u00eda L, Vezza T, Cenis-Cifuentes L, Rodr\u00edguez-Sojo MJ, Cenis JL, Rodr\u00edguez-Cabezas ME, Rodr\u00edguez-Nogales A, G\u00e1lvez J (2021) Lozano-P\u00e9rez, Silk fibroin nanoparticles enhance quercetin immunomodulatory properties in DSS-induced mouse colitis. Int J Pharm 606:120935. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120935","journal-title":"Int J Pharm"},{"key":"11888_CR76","doi-asserted-by":"publisher","unstructured":"Homayun B, Lin X, Choi HJ (2019) Challenges and recent progress in oral drug delivery systems for biopharmaceuticals, Pharmaceutics 11. 129. https:\/\/doi.org\/10.3390\/pharmaceutics11030129","DOI":"10.3390\/pharmaceutics11030129"},{"key":"11888_CR77","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.drudis.2011.01.003","volume":"16","author":"M O\u2019Neill","year":"2011","unstructured":"O\u2019Neill M, Bourre L, Melgar S, O\u2019Driscoll CM (2011) Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models. Drug Discovery Today 16:203\u2013218. https:\/\/doi.org\/10.1016\/j.drudis.2011.01.003","journal-title":"Drug Discovery Today"},{"key":"11888_CR78","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41575-019-0172-4","volume":"16","author":"Y Na","year":"2019","unstructured":"Na Y, Stakenborg, Seok SH, Matteoli G (2019) Macrophages in intestinal inflammation and resolution: a potential therapeutic target in IBD. Nat Rev Gastroenterol Hepatol 16:531\u2013543. https:\/\/doi.org\/10.1038\/s41575-019-0172-4","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11888_CR79","doi-asserted-by":"publisher","unstructured":"Rai R, Alwani S, Badea I (2019) Polymeric nanoparticles in gene therapy: New avenues of design and optimization for delivery applications, Polymers 11. 4745. https:\/\/doi.org\/10.3390\/polym11040745","DOI":"10.3390\/polym11040745"},{"key":"11888_CR80","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/mt.2012.185","volume":"21","author":"R Benjaminsen","year":"2013","unstructured":"Benjaminsen R, Mattebjerg M, Henriksen J, Moghimi S, Andresen T (2013) The possible proton sponge effect of polyethylenimine (PEI) does not include change in lysosomal pH. Mol Ther 21:149\u2013157. https:\/\/doi.org\/10.1038\/mt.2012.185","journal-title":"Mol Ther"},{"key":"11888_CR81","doi-asserted-by":"publisher","unstructured":"Laroui H, Theiss A, Yan Y, Dalmasso G, Nguyen HT, Sitaraman SV, Merlin D (2011) Functional TNF\u03b1 gene silencing mediated by polyethyleneimine\/TNF\u03b1 siRNA nanocomplexes in inflamed colon Biomaterials 32. 41218\u20131228. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.09.062","DOI":"10.1016\/j.biomaterials.2010.09.062"},{"key":"11888_CR82","doi-asserted-by":"publisher","first-page":"5156","DOI":"10.3390\/md13085156","volume":"13","author":"R Cheung","year":"2015","unstructured":"Cheung R, Ng T, Wong J, Chan WY (2015) Chitosan: an update on potential biomedical and pharmaceutical applications. Mar Drugs 13:5156\u20135186. https:\/\/doi.org\/10.3390\/md13085156","journal-title":"Mar Drugs"},{"key":"11888_CR83","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jconrel.2005.05.004","volume":"106","author":"M Huang","year":"2005","unstructured":"Huang M, Fong C, Khor E, Lim LY (2005) Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J Controlled Release 106:391\u2013406. https:\/\/doi.org\/10.1016\/j.jconrel.2005.05.004","journal-title":"J Controlled Release"},{"key":"11888_CR84","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S0168-3659(00)00361-8","volume":"70","author":"H Mao","year":"2001","unstructured":"Mao H, Roy K, Troung-Le V, Janes K, Lin K, Wang Y, August J, Leong K (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Controlled Release 70:399\u2013421. https:\/\/doi.org\/10.1016\/S0168-3659(00)00361-8","journal-title":"J Controlled Release"},{"key":"11888_CR85","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/gut.2009.184556","volume":"59","author":"L Zuo","year":"2010","unstructured":"Zuo L, Huang Z, Dong L, Xu L, Zhu Y, Zeng K, Zhang C, Chen J, Zhang J (2010) Targeting delivery of anti-TNF\u03b1 oligonucleotide into activated colonic macrophages protects against experimental colitis). Gut 59:470\u2013447. https:\/\/doi.org\/10.1136\/gut.2009.184556","journal-title":"Gut"},{"key":"11888_CR86","doi-asserted-by":"publisher","unstructured":"Byrne M, Victory D, Hibbitts A, Lanigan M, Heise A, Cryan S (2013) Molecular weight and architectural dependence of well-defined star-shaped poly (lysine) as a gene delivery vector. Biomaterials science 121223\u20131234. https:\/\/doi.org\/10.1039\/C3BM60123D","DOI":"10.1039\/C3BM60123D"},{"key":"11888_CR87","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jconrel.2016.08.017","volume":"239","author":"Y Song","year":"2016","unstructured":"Song Y, Kim Y, Kim S, Ain Q, Jang K, Yang C, Kim Y (2016) RNAi-mediated silencing of TNF-\u03b1 converting enzyme to down-regulate soluble TNF-\u03b1 production for treatment of acute and chronic colitis. J Controlled Release 239:231\u2013224. https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.017","journal-title":"J Controlled Release"},{"key":"11888_CR88","doi-asserted-by":"publisher","unstructured":"Bhavsar M, of controlled release MA-J (2007) undefined Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS), Journal of controlled release 119(3):339\u2013348. https:\/\/doi.org\/10.1016\/j.jconrel.2007.03.006","DOI":"10.1016\/j.jconrel.2007.03.006"},{"key":"11888_CR89","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jconrel.2005.11.001","volume":"110","author":"MD Bhavsar","year":"2006","unstructured":"Bhavsar MD, Tiwari SB, Amiji MM (2006) Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. J Controlled Release 110:422\u2013430. https:\/\/doi.org\/10.1016\/j.jconrel.2005.11.001","journal-title":"J Controlled Release"},{"key":"11888_CR90","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/IBD\/IZY123","volume":"24","author":"M Zhang","year":"2018","unstructured":"Zhang M, Merlin D (2018) Nanoparticle-Based Oral Drug Delivery Systems Targeting the Colon for Treatment of Ulcerative Colitis. Inflamm Bowel Dis 24:1401\u20131415. https:\/\/doi.org\/10.1093\/IBD\/IZY123","journal-title":"Inflamm Bowel Dis"},{"key":"11888_CR91","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1080\/10717544.2018.1501119","volume":"25","author":"J Reinholz","year":"2018","unstructured":"Reinholz J, Landfester K, Mail\u00e4nder V (2018) The challenges of oral drug delivery via nanocarriers. Drug Deliv 25:1694\u20131705. https:\/\/doi.org\/10.1080\/10717544.2018.1501119","journal-title":"Drug Deliv"},{"key":"11888_CR92","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/J.IJPHARM.2014.05.047","volume":"472","author":"F Hintzen","year":"2014","unstructured":"Hintzen F, Perera G, Hauptstein S, M\u00fcller C, Laffleur F, Bernkop-Schn\u00fcrch A (2014) In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm 472:20\u201326. https:\/\/doi.org\/10.1016\/J.IJPHARM.2014.05.047","journal-title":"Int J Pharm"},{"key":"11888_CR93","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ijmm.2007.05.004","volume":"298","author":"JA Wang","year":"2008","unstructured":"Wang JA, Meyer TF, Rudel T (2008) Cytoskeleton and motor proteins are required for the transcytosis of Neisseria gonorrhoeae through polarized epithelial cells. Int J Med Microbiol 298:209\u2013221. https:\/\/doi.org\/10.1016\/j.ijmm.2007.05.004","journal-title":"Int J Med Microbiol"},{"key":"11888_CR94","doi-asserted-by":"publisher","first-page":"12380","DOI":"10.1039\/D0TC02850A","volume":"8","author":"P Jiang","year":"2020","unstructured":"Jiang P, Ji Z, Wang X, Zhou F (2020) Surface functionalization \u2013 a new functional dimension added to 3D printing. J Mater Chem C Mater 8:12380\u201312411. https:\/\/doi.org\/10.1039\/D0TC02850A","journal-title":"J Mater Chem C Mater"},{"key":"11888_CR95","doi-asserted-by":"publisher","unstructured":"Fei Y, Ma Y, Zhang H, Li H, Feng G, Fang J (2022) Nanotechnology for research and treatment of the intestine. J Nanobiotechnol 20. https:\/\/doi.org\/10.1186\/S12951-022-01517-3","DOI":"10.1186\/S12951-022-01517-3"},{"key":"11888_CR96","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/S41565-020-00810-2","volume":"16","author":"A Cifuentes-Rius","year":"2021","unstructured":"Cifuentes-Rius A, Desai A, Yuen D, Johnston APR, Voelcker NH (2021) Inducing immune tolerance with dendritic cell-targeting nanomedicines. Nat Nanotechnol 16:37\u201346. https:\/\/doi.org\/10.1038\/S41565-020-00810-2","journal-title":"Nat Nanotechnol"},{"key":"11888_CR97","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/NRGASTRO.2015.37","volume":"12","author":"A Lamprecht","year":"2015","unstructured":"Lamprecht A (2015) Nanomedicines in gastroenterology and hepatology. Nat Rev Gastroenterol Hepatol 12:195\u2013204. https:\/\/doi.org\/10.1038\/NRGASTRO.2015.37","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11888_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14715\/cmb\/2023.69.4.1","volume":"69","author":"T Naseriyeh","year":"2023","unstructured":"Naseriyeh T, Kahrizi D, Alvandi H, Aghaz F, Nowroozi G, Shamsi A, Hosseini O, Arkan E (2023) Glycyrrhizic acid delivery system Chitosan-coated liposome as an adhesive anti-inflammation for the simultaneous delivery of several drugs with dif. Cell Mol Biol 69:1\u20136. https:\/\/doi.org\/10.14715\/cmb\/2023.69.4.1","journal-title":"Cell Mol Biol"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-11888-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-11888-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T07:26:45Z","timestamp":1777966005000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-11888-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11888"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-11888-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"6 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article is a review and does not involve any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"712"}}